HK1025562A1 - Solid compositions suitable for oral administration comprising l-carnitine choline tartrate - Google Patents
Solid compositions suitable for oral administration comprising l-carnitine choline tartrateInfo
- Publication number
- HK1025562A1 HK1025562A1 HK00102419A HK00102419A HK1025562A1 HK 1025562 A1 HK1025562 A1 HK 1025562A1 HK 00102419 A HK00102419 A HK 00102419A HK 00102419 A HK00102419 A HK 00102419A HK 1025562 A1 HK1025562 A1 HK 1025562A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pct
- solid compositions
- carnitine
- oral administration
- compositions suitable
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
- QWJSAWXRUVVRLH-LREBCSMRSA-M 2-hydroxyethyl(trimethyl)azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound C[N+](C)(C)CCO.OC(=O)[C@H](O)[C@@H](O)C([O-])=O QWJSAWXRUVVRLH-LREBCSMRSA-M 0.000 title abstract 2
- 239000008247 solid mixture Substances 0.000 title abstract 2
- 229960001518 levocarnitine Drugs 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000000378 dietary effect Effects 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000222A IT1291143B1 (it) | 1997-04-18 | 1997-04-18 | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina |
PCT/IT1998/000080 WO1998047857A1 (en) | 1997-04-18 | 1998-04-08 | Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1025562A1 true HK1025562A1 (en) | 2000-11-17 |
Family
ID=11404982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00102419A HK1025562A1 (en) | 1997-04-18 | 2000-04-20 | Solid compositions suitable for oral administration comprising l-carnitine choline tartrate |
Country Status (17)
Country | Link |
---|---|
US (1) | US6080786A (ja) |
EP (1) | EP0975581B1 (ja) |
JP (1) | JP4046361B2 (ja) |
KR (1) | KR100562052B1 (ja) |
AT (1) | ATE208759T1 (ja) |
AU (1) | AU731223B2 (ja) |
BR (1) | BR9808908B1 (ja) |
CA (1) | CA2286631C (ja) |
DE (1) | DE69802518T2 (ja) |
DK (1) | DK0975581T3 (ja) |
ES (1) | ES2167889T3 (ja) |
HK (1) | HK1025562A1 (ja) |
IT (1) | IT1291143B1 (ja) |
NZ (1) | NZ500535A (ja) |
PT (1) | PT975581E (ja) |
SI (1) | SI0975581T1 (ja) |
WO (1) | WO1998047857A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1306147B1 (it) | 1999-05-28 | 2001-05-30 | Biosalts Srl | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali |
IT1306186B1 (it) * | 1999-09-03 | 2001-05-30 | Biosalts Srl | Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale |
DE19956772A1 (de) * | 1999-11-25 | 2001-06-07 | Basf Ag | Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung |
DE10350140A1 (de) * | 2003-03-28 | 2004-10-14 | Martin Schymura | Fruchtgummizusammensetzung |
BR102016009579A2 (pt) * | 2016-04-28 | 2017-10-31 | Geralatex Indl E Coml Prod Agro Florestais | Nutritional food supplement formulated on the basis of pulp or humid watermelon factor, modified by hydration or reidrating, also known as tapioca, used as a source of carbohydrates and nucleus for formulations for food and dietary supplementation or, still as a partial substitute of meals for athletes or practicers of physical activities, its compositions and process |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1153640A (en) * | 1967-04-10 | 1969-05-29 | Soc D Etudes Prod Chimique | A Carnitin Salt |
FR2529545B1 (fr) * | 1982-07-02 | 1985-05-31 | Sanofi Sa | Nouveaux sels de carnitine ainsi que leur procede de preparation |
EP0150688B1 (en) * | 1983-12-28 | 1987-04-22 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
US5001117A (en) * | 1989-03-07 | 1991-03-19 | Pharmacaps, Inc. | Use of lecithin to restore olfaction and taste |
CA2018137C (en) * | 1989-06-14 | 2000-01-11 | Thomas Scholl | L-carnitine magnesium citrate |
US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
IT1261688B (it) * | 1993-05-28 | 1996-05-29 | Avantgarde Spa | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
-
1997
- 1997-04-18 IT IT97RM000222A patent/IT1291143B1/it active IP Right Grant
-
1998
- 1998-04-04 US US09/402,650 patent/US6080786A/en not_active Expired - Fee Related
- 1998-04-08 PT PT98917598T patent/PT975581E/pt unknown
- 1998-04-08 JP JP54538898A patent/JP4046361B2/ja not_active Expired - Fee Related
- 1998-04-08 EP EP98917598A patent/EP0975581B1/en not_active Expired - Lifetime
- 1998-04-08 ES ES98917598T patent/ES2167889T3/es not_active Expired - Lifetime
- 1998-04-08 DE DE69802518T patent/DE69802518T2/de not_active Expired - Lifetime
- 1998-04-08 SI SI9830051T patent/SI0975581T1/xx unknown
- 1998-04-08 AU AU70777/98A patent/AU731223B2/en not_active Ceased
- 1998-04-08 BR BRPI9808908-0A patent/BR9808908B1/pt not_active IP Right Cessation
- 1998-04-08 NZ NZ500535A patent/NZ500535A/en unknown
- 1998-04-08 DK DK98917598T patent/DK0975581T3/da active
- 1998-04-08 WO PCT/IT1998/000080 patent/WO1998047857A1/en not_active Application Discontinuation
- 1998-04-08 KR KR1019997009473A patent/KR100562052B1/ko not_active IP Right Cessation
- 1998-04-08 AT AT98917598T patent/ATE208759T1/de not_active IP Right Cessation
- 1998-04-08 CA CA002286631A patent/CA2286631C/en not_active Expired - Fee Related
-
2000
- 2000-04-20 HK HK00102419A patent/HK1025562A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1291143B1 (it) | 1998-12-29 |
CA2286631C (en) | 2008-07-08 |
BR9808908B1 (pt) | 2011-02-08 |
KR100562052B1 (ko) | 2006-03-17 |
DK0975581T3 (da) | 2002-03-25 |
DE69802518T2 (de) | 2002-05-16 |
US6080786A (en) | 2000-06-27 |
ATE208759T1 (de) | 2001-11-15 |
BR9808908A (pt) | 2000-08-01 |
PT975581E (pt) | 2002-04-29 |
EP0975581A1 (en) | 2000-02-02 |
DE69802518D1 (de) | 2001-12-20 |
SI0975581T1 (en) | 2002-06-30 |
JP4046361B2 (ja) | 2008-02-13 |
JP2002512613A (ja) | 2002-04-23 |
NZ500535A (en) | 2001-03-30 |
AU7077798A (en) | 1998-11-13 |
ES2167889T3 (es) | 2002-05-16 |
WO1998047857A1 (en) | 1998-10-29 |
AU731223B2 (en) | 2001-03-29 |
KR20010006386A (ko) | 2001-01-26 |
EP0975581B1 (en) | 2001-11-14 |
ITRM970222A1 (it) | 1998-10-18 |
CA2286631A1 (en) | 1998-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1025559A1 (en) | Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate | |
DK0973515T3 (da) | Faste sammensætninger, der er egnet til oral indgivelse, hvilke sammensætninger omfatter et alkanoyl-L-carnitinmagnesiumcitrat | |
HK1025561A1 (en) | Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate | |
HK1025562A1 (en) | Solid compositions suitable for oral administration comprising l-carnitine choline tartrate | |
HK1025560A1 (en) | Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110408 |